C3 glomerulonephritis: a new category of glomerulonephritis with etiopathogenic implications

被引:0
|
作者
Taborda Murillo, Alejandra [1 ]
Arroyave Suarez, Mariam Jose [1 ]
Fernando Arias, Luis [2 ]
机构
[1] Univ Antioquia, Fac Med, Patol, Medellin, Colombia
[2] Univ Antioquia, Fac Med, Dept Patol, Grp Patol Renal & Trasplantes PRYT, Medellin, Colombia
关键词
Alternative Complement Pathway; C3; Glomerulone-phritis; Glomerulopathy; Renal Disease;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Glomerulonephritis with only deposits of C3 (GN-C3) could involve alteration on the complement alternative pathway. Objective: To describe retrospectively a series of GN-C3 cases and to determine the frequency with which patients continue with renal alterations and/or hypo-complementemia. Methods: The 22 cases of GN-C3 diagnosed between 2004 and 2012 at the Department of Pathology, Faculty of Medicine, University of Antioquia (Medellin, Colombia) were included. Their histological and clinical characteristics and their outcome were evaluated. Results: 14 patients were children and 12 were males. Mean age was 13 years (range: 3-65). Ten presented as a nephritic syndrome, seven as a rapidly progressive GN, three as acute renal failure, one as chronic renal failure, and one as a nephrotic-nephritic syndrome. The C3 fraction of complement was low in 21 cases. All biopsies showed proliferative GN. There was complete remission in eight patients, persistent urinalysis alterations in four, chronic renal failure in six, five of them end-stage. No follow-up was done in four. In nine patients follow-up determination of C3 serum levels was done; in all of them they normalized between 1 to 3 months after biopsy. Conclusions: GN-C3 can produce persistent or recurrent kidney alterations and end-stage renal disease. Long-term follow-up with repeated determinations of C3 is advisable.
引用
收藏
页码:24 / 34
页数:11
相关论文
共 50 条
  • [21] A CASE WITH ISOLATED C3 MESANGIOPROLIPHERATIVE GLOMERULONEPHRITIS
    Gulleroglu, K.
    Bayrakci, U. S.
    Haberal, N.
    Cengiz, N.
    Baskin, E.
    PEDIATRIC NEPHROLOGY, 2009, 24 (09) : 1830 - 1830
  • [22] Timing of eculizumab therapy for C3 glomerulonephritis
    Rodriguez-Osorio, Laura
    Ortiz, Alberto
    CLINICAL KIDNEY JOURNAL, 2015, 8 (04): : 449 - 452
  • [23] C3 glomerulonephritis with a severe crescentic phenotype
    Aishwarya Ravindran
    Fernando C. Fervenza
    Richard J. H. Smith
    Sanjeev Sethi
    Pediatric Nephrology, 2017, 32 : 1625 - 1633
  • [24] C3 glomerulonephritis with a severe crescentic phenotype
    Ravindran, Aishwarya
    Fervenza, Fernando C.
    Smith, Richard J. H.
    Sethi, Sanjeev
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1625 - 1633
  • [25] C3 Glomerulonephritis Associated with Monoclonal Gammopathy
    Piedade, Ana D.
    Domingues, Patricia A.
    Inacio, Antonio S.
    Mendes, Beatriz B.
    Parreira, Lucia F.
    INDIAN JOURNAL OF NEPHROLOGY, 2024, 34 (06) : 660 - 662
  • [26] C3 convertase antibodies in membranoproliferative glomerulonephritis
    Lindner, S.
    Chen, Q.
    Kirschfink, M.
    Nilsson, B.
    Nilsson-Ekdah, K.
    Wolf, G.
    Zipfel, P. F.
    MOLECULAR IMMUNOLOGY, 2013, 56 (03) : 286 - 286
  • [27] C3 nephritic factor and mesangiocapillary glomerulonephritis
    D. Gwyn Williams
    Pediatric Nephrology, 1997, 11 : 96 - 98
  • [28] C3 glomerulonephritis: a department's series
    Veiga, R.
    Manso, R.
    Gaspar, A.
    Lopez, N.
    Soto, K.
    Serra, A.
    VIRCHOWS ARCHIV, 2018, 473 : S82 - S82
  • [29] Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative glomerulonephritis
    Kawasaki, Yukihiko
    Kanno, Syuto
    Ono, Atsushi
    Suzuki, Yuichi
    Ohara, Shinichiro
    Sato, Masatoki
    Suyama, Kazuhide
    Hashimoto, Koichi
    Hosoya, Mitsuaki
    PEDIATRIC NEPHROLOGY, 2016, 31 (07) : 1091 - 1099
  • [30] A Case of Switch from C3 Glomerulonephritis to Proliferative Glomerulonephritis with Monoclonal IgG Deposits
    Zhang, Fan
    Gao, Erzhi
    Liang, Shaoshan
    Yang, Nannan
    Wang, Jinquan
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2018, 48 (04): : 528 - 533